Trial intelligence / Profile preview

Pharmacokinetics of Amlodipine at Delivery and During Lactation

NCT02353806Phase 4Completed

Sponsor
UT Southwestern Medical Center
Start
Jan 2015
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of amlodipine in hypertension (HTN), sponsored by UT Southwestern Medical Center. Primary endpoints: Area Under the Curve for Amlodipine in Maternal Serum at 24 hours, Time to Maximal Concentration in Maternal Serum at 24 hours and 6 more. Started Jan 2015; status: completed.

02

Drugs

amlodipine
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT02353806.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02353806.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call